ViewPoint Therapeutics Competitors and Similar CompaniesClear all

ViewPoint Therapeutics's competitors and similar companies include Molecular Partners and Prevail Therapeutics.
ViewPoint Therapeutics
ViewPoint Therapeutics
ViewPoint Therapeutics is a biotechnology company which develops treatments for diseases of protein misfolding, including cataracts.
Molecular Partners
Molecular Partners
Molecular Partners is a company that develops biopharmaceutical products for serious diseases.
Prevail Therapeutics
Prevail Therapeutics
Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease.
Founding Date
Founding Date
2014
Founding Date
2004
Founding Date
2017
Type
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
San Mateo, US HQ
San Francisco, US
Locations
Zürich-Schlieren, CH HQ
Cambridge, US
Concord, US
Locations
New York, US HQ
Employees
Employees
1
Employees
158
Employees
489% increase

Financial

Net income
Net income
N/A
Net income
(CHF61.7m) (FY, 2025)
Net income
($63.2m) (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 39m
Total funding raised
N/A
Total funding raised
$ 125m
For sources of this data, please see the company profile

View Company Profiles

Molecular Partners
HQ
Zürich-Schlieren, CH
Employees
158

Molecular Partners is a company that develops biopharmaceutical products for serious diseases.

View company
Prevail Therapeutics
HQ
New York, US
Employees
48↑ 9% increase

Prevail Therapeutics is a biotech company that is developing therapeutics for neurodegenerative disorders, such as Parkinson's disease.

View company